65,437 trials
Urodynamics
Primary: Maximum Vesical Pressure During Valsalva Manoeuvres — 39.31; 39.44 cmH2O
Low Back Pain, Recurrent
Primary: Leg Length Inequality — 0.3; 0.58 centemeter
Sinus Node Disfunction
Primary: Absolute Change in the Proportion of Subjects Diagnosed With SND at Pre Specific Time. — 69; 70 Participants
Chronic Idiopathic Constipation
Primary: Proportion of Overall Responders — 7; 10; 12; 7 Participants
Depressive Symptoms
Primary: Depressive Symptoms Measured by Beck Depression Inventory-II — 17.33; 18.04; 18.13; 10.96 units on a scale — p=.05
Schizophrenia
Primary: VO2max — 4.0; 0.2 ml.kg-1.min-1 — p=0.02
Mitral Stenosis With Insufficiency · Functional Mitral Regurgitation · Mitral Insufficiency
Primary: Number of Participants With Acute Procedure Success (APS) — 26 Participants
Breast Cancer · Lymphedema
Primary: Arm Volume — 1.48; 1.58 cm^3
Autonomic Nervous System Imbalance
Primary: Change in High Frequency Heart Rate Variability — 5.10; 5.14; 5.00; 5.12 Units on a Log Scale — p=<.02
Neonatal Abstinence Syndrome
Primary: Change in Finnegan Score — -1.5167; -0.2549 score on a scale
Patients With Compensated Liver Cirrhosis
Primary: CSPH (Clinically Significant Portal Hypertension) — 81.82 percentage of agreement
Contraception
Primary: Number of Participants Using an Effective Contraceptive Method 6 Weeks After Abortion — 55; 55 Participants
Healthy
Primary: Number of Participants With One or More Serious Adverse Event(s) (SAEs) — 0; 0; 0; 0 Participants
Postoperative Ileus · Anastomotic Leak
Primary: Number of Patients Developing Postoperative Ileus — 29; 37 Participants
Hypertension
Primary: Clinical Adoption of a Decision Support Artificial Intelligence — 10; 3 Participants